Long-term safety and efficacy of apomorphine infusion in Parkinson's disease (PD) patients with persistent motor fluctuations: results of the open-label phase of the TOLEDO study

被引：0
|
作者：
Katzenschlager, R.
Poewe, W.
Rascol, O. [1 ]
Trenkwalder, C. [2 ]
Deuschl, G. [3 ]
Chaudhuri, R. [4 ]
Henriksen, T. [5 ]
Van Laar, T. [6 ]
Lockhart, D. [7 ]
Lees, A. [8 ]
机构：
[1] Univ Toulouse, Dept Neurosci & Clin Pharmacol, Toulouse, France
[2] Paracelsus Elena Klin, Kassel, Germany
[3] Univ Kiel, Dept Neurol, Kiel, Germany
[4] Kings Coll Hosp NHS Fdn Trust, Natl Parkinson Fdn Int Ctr Excellence, London, England
[5] Univ Hosp Bispebjerg, Movement Disorder Clin, Copenhagen, Denmark
[6] Univ Med Ctr Groningen, Neurol, Groningen, Netherlands
[7] Britannia Pharmaceut, Reading, Berks, England
[8] Natl Hosp Neurol & Neurosurg, London, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR2058
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [21] Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease
    Hattori, Nobutaka
    Takeda, Atsushi
    Takeda, Shinichi
    Nishimura, Akira
    Kitagawa, Tadayuki
    Mochizuki, Hideki
    Nagai, Masahiro
    Takahashi, Ryosuke
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (03) : 299 - 308
  • [22] Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
    Nobutaka Hattori
    Atsushi Takeda
    Shinichi Takeda
    Akira Nishimura
    Tadayuki Kitagawa
    Hideki Mochizuki
    Masahiro Nagai
    Ryosuke Takahashi
    Journal of Neural Transmission, 2019, 126 : 299 - 308
  • [23] LONG-TERM SAFETY AND EFFICACY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE: FINAL RESULTS FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip J.
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, Weijiang
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1198
  • [24] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [25] Long-term safety and efficacy of risankizumab treatment in patients with Crohn's disease: Final results from the Phase 2 open-label extension study
    Ferrante, M.
    Feagan, B. G.
    Panes, J.
    Baert, F.
    Louis, E.
    Dewit, O.
    Kaser, A.
    Duan, W. R.
    Gustafson, D.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G. R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S024 - S025
  • [26] Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson<acute accent>s Disease
    Peball, Marina
    Heim, Beatrice
    Carbone, Federico
    Schorr, Oliver
    Werkmann, Mario
    Ellmerer, Philipp
    Marini, Kathrin
    Krismer, Florian
    Knaus, Hans-Guenther
    Poewe, Werner
    Djamshidian, Atbin
    Seppi, Klaus
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [27] Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study
    Emre, Murat
    Poewe, Werner
    De Deyn, Peter Paul
    Barone, Paolo
    Kulisevsky, Jaime
    Pourcher, Emmanuelle
    van Laar, Teus
    Storch, Alexander
    Micheli, Federico
    Burn, David
    Durif, Frank
    Pahwa, Rajesh
    Callegari, Francesca
    Tenenbaum, Nadia
    Strohmaier, Christine
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (01) : 9 - 16
  • [28] Long-term safety and efficacy of opicapone in Japanese Parkinson's patients with motor fluctuations
    Takeda, Atsushi
    Takahashi, Ryosuke
    Tsuboi, Yoshio
    Nomoto, Masahiro
    Maeda, Tetsuya
    Nishimura, Akihisa
    Yoshida, Kazuo
    Hattori, Nobutaka
    JOURNAL OF NEURAL TRANSMISSION, 2021, 128 (03) : 337 - 344
  • [29] Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations
    Atsushi Takeda
    Ryosuke Takahashi
    Yoshio Tsuboi
    Masahiro Nomoto
    Tetsuya Maeda
    Akihisa Nishimura
    Kazuo Yoshida
    Nobutaka Hattori
    Journal of Neural Transmission, 2021, 128 : 337 - 344
  • [30] Effect of Prasinezumab on Parkinson's disease (PD) Motor Progression in a Long-term Open-label Extension of the PASADENA Trial
    Pagano, G.
    Monnet, A.
    Reyes, A.
    Ribba, B.
    Svoboda, H.
    Kustermann, T.
    Simuni, T.
    Postuma, R.
    Pavese, N.
    Stocchi, F.
    Brockmann, K.
    Smigorski, K.
    Gerbaldo, V.
    Fontoura, P.
    Doody, R.
    Kerchner, G.
    Brundin, P.
    Marek, K.
    Bonni, A.
    Nikolcheva, T.
    MOVEMENT DISORDERS, 2024, 39 : S346 - S347
12345